These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1947 related articles for article (PubMed ID: 23973922)

  • 1. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation.
    Kim HS; Yun JW; Shin TH; Lee SH; Lee BC; Yu KR; Seo Y; Lee S; Kang TW; Choi SW; Seo KW; Kang KS
    Stem Cells; 2015 Apr; 33(4):1254-66. PubMed ID: 25522163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.
    Tang RJ; Shen SN; Zhao XY; Nie YZ; Xu YJ; Ren J; Lv MM; Hou YY; Wang TT
    Stem Cell Res Ther; 2015 Apr; 6(1):71. PubMed ID: 25889203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE
    Kim K; An JH; Park SM; Lim G; Seo KW; Youn HY
    J Vet Sci; 2023 Jul; 24(4):e52. PubMed ID: 37532297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
    Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
    Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood.
    Kim HS; Shin TH; Yang SR; Seo MS; Kim DJ; Kang SK; Park JH; Kang KS
    PLoS One; 2010 Oct; 5(10):e15369. PubMed ID: 21042538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis.
    Shin TH; Kim HS; Kang TW; Lee BC; Lee HY; Kim YJ; Shin JH; Seo Y; Won Choi S; Lee S; Shin K; Seo KW; Kang KS
    Cell Death Dis; 2016 Dec; 7(12):e2524. PubMed ID: 28005072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway.
    Luo X; Wang X; Huang S; Xu B; Luo S; Li Y; Wang Q; Chen Y; Deng X; Liu L; Zhou L
    Int Immunopharmacol; 2021 Jan; 90():107224. PubMed ID: 33302036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
    Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
    Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice.
    Niu GC; Liu L; Zheng L; Zhang H; Shih DQ; Zhang X
    BMC Gastroenterol; 2018 Aug; 18(1):127. PubMed ID: 30103680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
    Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
    Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
    Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
    Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.